Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States

J. Bryan Iorgulescu; Chuxuan Sun; Corey Neff; Gino Cioffi; Catherine Gutierrez; Carol Kruchko; Jennifer Ruhl; Kristin Waite; Serban Negoita; Jim Hofferkamp; Tarik Tihan; Roger McLendon; Daniel J. Brat; Quinn T. Ostrom; Jill S. Barnholtz-Sloan

doi:10.1093/neuonc/noac270

Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States

J. Bryan Iorgulescu, Chuxuan Sun, Corey Neff, Gino Cioffi, Catherine Gutierrez, Carol Kruchko, Jennifer Ruhl, Kristin Waite, Serban Negoita, Jim Hofferkamp, Tarik Tihan, Roger McLendon, Daniel J. Brat, Quinn T. Ostrom, Jill S. Barnholtz-Sloan

Pathology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	424-429
Number of pages	6
Journal	Neuro-oncology
Volume	25
Issue number	2
DOIs	https://doi.org/10.1093/neuonc/noac270
State	Published - Feb 14 2023

ASJC Scopus subject areas

Oncology
Clinical Neurology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/neuonc/noac270

Cite this

Iorgulescu, J. B., Sun, C., Neff, C., Cioffi, G., Gutierrez, C., Kruchko, C., Ruhl, J., Waite, K., Negoita, S., Hofferkamp, J., Tihan, T., McLendon, R., Brat, D. J., Ostrom, Q. T., & Barnholtz-Sloan, J. S. (2023). Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States. Neuro-oncology, 25(2), 424-429. https://doi.org/10.1093/neuonc/noac270

@article{bb6345a30cc44c50b4e98bee9fcf5ac7,

title = "Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States",

author = "Iorgulescu, {J. Bryan} and Chuxuan Sun and Corey Neff and Gino Cioffi and Catherine Gutierrez and Carol Kruchko and Jennifer Ruhl and Kristin Waite and Serban Negoita and Jim Hofferkamp and Tarik Tihan and Roger McLendon and Brat, {Daniel J.} and Ostrom, {Quinn T.} and Barnholtz-Sloan, {Jill S.}",

year = "2023",

month = feb,

day = "14",

doi = "10.1093/neuonc/noac270",

language = "English (US)",

volume = "25",

pages = "424--429",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "2",

}

Iorgulescu, JB, Sun, C, Neff, C, Cioffi, G, Gutierrez, C, Kruchko, C, Ruhl, J, Waite, K, Negoita, S, Hofferkamp, J, Tihan, T, McLendon, R, Brat, DJ, Ostrom, QT & Barnholtz-Sloan, JS 2023, 'Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States', Neuro-oncology, vol. 25, no. 2, pp. 424-429. https://doi.org/10.1093/neuonc/noac270

TY - JOUR

T1 - Corrigendum to

T2 - Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States

AU - Iorgulescu, J. Bryan

AU - Sun, Chuxuan

AU - Neff, Corey

AU - Cioffi, Gino

AU - Gutierrez, Catherine

AU - Kruchko, Carol

AU - Ruhl, Jennifer

AU - Waite, Kristin

AU - Negoita, Serban

AU - Hofferkamp, Jim

AU - Tihan, Tarik

AU - McLendon, Roger

AU - Brat, Daniel J.

AU - Ostrom, Quinn T.

AU - Barnholtz-Sloan, Jill S.

PY - 2023/2/14

Y1 - 2023/2/14

UR - http://www.scopus.com/inward/record.url?scp=85148112999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148112999&partnerID=8YFLogxK

U2 - 10.1093/neuonc/noac270

DO - 10.1093/neuonc/noac270

M3 - Comment/debate

C2 - 36534983

AN - SCOPUS:85148112999

SN - 1522-8517

VL - 25

SP - 424

EP - 429

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - 2

ER -

Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this